Gengos Andrew

EDGAR CIK 0001563623

Athira Pharma, Inc. - ATHA

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CFO
CFO and Chief Business Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($4,235)
-2,480 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/05/2024
09/05/2024
Sell
-1,272 @ $0.57
 ($720) 97,532 (-1.29%) Direct
01/05/2024
02/16/2024
Sell
-1,208 @ $2.91
 ($3,515) 83,804 (-1.42%) Direct